The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation

BACKGROUND: BRAF (v-raf murine sarcoma viral oncogene homolog B1) V600E mutant colorectal cancer is associated with short survival. Recently, clinical trials have been conducted to improve outcomes of second or later lines of chemotherapy. However, there is a paucity of reference data pertaining to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Med Oncol
Main Authors: Mitani, Seiichiro, Taniguchi, Hiroya, Sugiyama, Keiji, Masuishi, Toshiki, Honda, Kazunori, Narita, Yukiya, Kadowaki, Shigenori, Ura, Takashi, Ando, Masashi, Tajika, Masahiro, Yatabe, Yasushi, Muro, Kei
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6348546/
https://ncbi.nlm.nih.gov/pubmed/30719102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835918820298
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados